228 related articles for article (PubMed ID: 25075007)
1. The RECK gene and biological malignancy--its significance in angiogenesis and inhibition of matrix metalloproteinases.
Alexius-Lindgren M; Andersson E; Lindstedt I; Engström W
Anticancer Res; 2014 Aug; 34(8):3867-73. PubMed ID: 25075007
[TBL] [Abstract][Full Text] [Related]
2. RECK, a novel matrix metalloproteinase regulator.
Meng N; Li Y; Zhang H; Sun XF
Histol Histopathol; 2008 Aug; 23(8):1003-10. PubMed ID: 18498076
[TBL] [Abstract][Full Text] [Related]
3. Potential Role of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Regulation of Matrix Metalloproteinases (MMPs) Expression in Periodontal Diseases.
Liu N; Zhou B; Zhu G
Med Sci Monit; 2016 Jun; 22():1936-8. PubMed ID: 27272560
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2.
Jacomasso T; Trombetta-Lima M; Sogayar MC; Winnischofer SM
Melanoma Res; 2014 Feb; 24(1):32-9. PubMed ID: 24335752
[TBL] [Abstract][Full Text] [Related]
5. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis.
Oh J; Takahashi R; Kondo S; Mizoguchi A; Adachi E; Sasahara RM; Nishimura S; Imamura Y; Kitayama H; Alexander DB; Ide C; Horan TP; Arakawa T; Yoshida H; Nishikawa S; Itoh Y; Seiki M; Itohara S; Takahashi C; Noda M
Cell; 2001 Dec; 107(6):789-800. PubMed ID: 11747814
[TBL] [Abstract][Full Text] [Related]
6. A Hypothesis for the Role of RECK in Angiogenesis.
Gutiérrez J; Droppelmann CA; Salsoso R; Westermeier F; Toledo F; Salomon C; Sanhueza C; Pardo F; Leiva A; Sobrevia L
Curr Vasc Pharmacol; 2016; 14(1):106-15. PubMed ID: 26463982
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases-2, -9 and reversion-inducing cysteine-rich protein with Kazal motifs in gingiva in periodontal health and disease.
Liu N; Cao Y; Zhu G
Arch Oral Biol; 2017 Mar; 75():62-67. PubMed ID: 28043014
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma.
Span PN; Sweep CG; Manders P; Beex LV; Leppert D; Lindberg RL
Cancer; 2003 Jun; 97(11):2710-5. PubMed ID: 12767082
[TBL] [Abstract][Full Text] [Related]
9. RECKing MMP: relevance of reversion-inducing cysteine-rich protein with kazal motifs as a prognostic marker and therapeutic target for cancer (a review).
Nagini S
Anticancer Agents Med Chem; 2012 Sep; 12(7):718-25. PubMed ID: 22292753
[TBL] [Abstract][Full Text] [Related]
10. RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer.
Clark JC; Thomas DM; Choong PF; Dass CR
Cancer Metastasis Rev; 2007 Dec; 26(3-4):675-83. PubMed ID: 17828469
[TBL] [Abstract][Full Text] [Related]
11. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
[TBL] [Abstract][Full Text] [Related]
12. The ß1-integrin-dependent function of RECK in physiologic and tumor angiogenesis.
Miki T; Shamma A; Kitajima S; Takegami Y; Noda M; Nakashima Y; Watanabe K; Takahashi C
Mol Cancer Res; 2010 May; 8(5):665-76. PubMed ID: 20407016
[TBL] [Abstract][Full Text] [Related]
13. Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.
Song SY; Son HJ; Nam E; Rhee JC; Park C
Eur J Cancer; 2006 Jan; 42(1):101-8. PubMed ID: 16324834
[TBL] [Abstract][Full Text] [Related]
14. RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling.
Noda M; Oh J; Takahashi R; Kondo S; Kitayama H; Takahashi C
Cancer Metastasis Rev; 2003; 22(2-3):167-75. PubMed ID: 12784995
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.
Namwat N; Puetkasichonpasutha J; Loilome W; Yongvanit P; Techasen A; Puapairoj A; Sripa B; Tassaneeyakul W; Khuntikeo N; Wongkham S
J Gastroenterol; 2011 May; 46(5):664-75. PubMed ID: 21076843
[TBL] [Abstract][Full Text] [Related]
17. Dual effects of the membrane-anchored MMP regulator RECK on chondrogenic differentiation of ATDC5 cells.
Kondo S; Shukunami C; Morioka Y; Matsumoto N; Takahashi R; Oh J; Atsumi T; Umezawa A; Kudo A; Kitayama H; Hiraki Y; Noda M
J Cell Sci; 2007 Mar; 120(Pt 5):849-57. PubMed ID: 17298979
[TBL] [Abstract][Full Text] [Related]
18. RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation.
Hong KJ; Wu DC; Cheng KH; Chen LT; Hung WC
J Cell Physiol; 2014 Feb; 229(2):191-201. PubMed ID: 23881612
[TBL] [Abstract][Full Text] [Related]
19. Reversion-inducing cysteine-rich protein with Kazal motif (RECK) expression: an independent prognostic marker of survival in colorectal cancer.
Stenzinger A; von Winterfeld M; Rabien A; Warth A; Kamphues C; Dietel M; Weichert W; Klauschen F; Wittschieber D
Hum Pathol; 2012 Aug; 43(8):1314-21. PubMed ID: 22397871
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression.
Xin C; Buhe B; Hongting L; Chuanmin Y; Xiwei H; Hong Z; Lulu H; Qian D; Renjie W
FEBS J; 2013 Feb; 280(3):855-66. PubMed ID: 23176145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
